132 related articles for article (PubMed ID: 2309000)
1. Transporting bone marrow for in vitro purging before autologous reinfusion.
Janssen WE; Gee AP; Graham-Pole JR; Lee C; Luzins J; Spencer C; Worthington-White DA; Pick T; Koch P; Gross S
Prog Clin Biol Res; 1990; 333():541-9. PubMed ID: 2309000
[TBL] [Abstract][Full Text] [Related]
2. A safe procedure for transporting bone-marrow for purging in a central laboratory.
Gazitt Y; Cantor A; Koza S; Grahampole J
Oncol Rep; 1994 Jan; 1(1):241-4. PubMed ID: 21607346
[TBL] [Abstract][Full Text] [Related]
3. Long-term cryopreservation of bone marrow for autologous transplantation.
Attarian H; Feng Z; Buckner CD; MacLeod B; Rowley SD
Bone Marrow Transplant; 1996 Mar; 17(3):425-30. PubMed ID: 8704699
[TBL] [Abstract][Full Text] [Related]
4. Processing and storage of human bone marrow: a survey of current practices in North America.
Areman EM; Sacher RA; Deeg HJ
Bone Marrow Transplant; 1990 Sep; 6(3):203-9. PubMed ID: 2252961
[TBL] [Abstract][Full Text] [Related]
5. Cryopreservation and storage of human bone marrow: a survey of current practices.
Areman EM; Sacher RA; Deeg HJ
Prog Clin Biol Res; 1990; 333():523-9. PubMed ID: 2308998
[TBL] [Abstract][Full Text] [Related]
6. The processing of human bone marrow for cryopreservation and reinfusion.
Weiner RS; Tobias JS; Yankee RA
Biomedicine; 1976; 24(4):226-31. PubMed ID: 11006
[TBL] [Abstract][Full Text] [Related]
7. Cryopreservation of human bone marrow after purging T-cells or tumor cells.
Zhang ZX; Xu YJ; Chen Y; Li Y; Shen BF; Bai Y
Cryobiology; 1994 Oct; 31(5):478-82. PubMed ID: 7988157
[TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of marrow cells for ABMT. Is there any effect on the harvested leukaemic cells?
Alessandrino EP; Bernasconi P; Lazzarino M; Castelli G; Bonfichi M; Caldera D; Colombo A; Boni M; Bernasconi C
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():81-4. PubMed ID: 2697444
[No Abstract] [Full Text] [Related]
9. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
10. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
[TBL] [Abstract][Full Text] [Related]
11. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation.
Rowley SD; Piantadosi S; Santos GW
Bone Marrow Transplant; 1989 Sep; 4(5):553-8. PubMed ID: 2790333
[TBL] [Abstract][Full Text] [Related]
12. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
Douay L; Lopez M; Gorin NC; Nauman A; Giarratana MC; Laporte JP; Stachowiak J; Salmon C; Duhamel G
Int J Cell Cloning; 1986 Jul; 4(4):250-62. PubMed ID: 2875118
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow processing with a gravity sedimentation technique: experience of 13 cases.
Adorno G; Tribalto M; Cantonetti M; di Toritto TC; Cudillo L; Dentamaro T; Iampieri MP; Lucanto E; Masi M; Riguzzi MC
Haematologica; 1990; 75 Suppl 1():48-50. PubMed ID: 1693588
[TBL] [Abstract][Full Text] [Related]
14. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
15. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.
Roodman GD; LeMaistre CF; Clark GM; Page CP; Newcomb TF; Knight WA
Bone Marrow Transplant; 1987 Aug; 2(2):165-73. PubMed ID: 3332164
[TBL] [Abstract][Full Text] [Related]
16. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation.
Stewart FM; Kaiser DL; Ishitani KP; Pirsch GW; Niskanen E
Exp Hematol; 1989 Oct; 17(9):974-80. PubMed ID: 2673831
[TBL] [Abstract][Full Text] [Related]
17. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
18. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
Lopez M; Mary JY; Sainteny F
Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
[TBL] [Abstract][Full Text] [Related]
19. [Technical aspects of autologous bone marrow transplantation].
Handgretinger R; Klingebiel T; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
[TBL] [Abstract][Full Text] [Related]
20. Contamination during in vitro processing of bone marrow for transplantation: clinical significance.
Lazarus HM; Magalhaes-Silverman M; Fox RM; Creger RJ; Jacobs M
Bone Marrow Transplant; 1991 Mar; 7(3):241-6. PubMed ID: 2059759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
